{"id":"W3092609933","doi":"10.1186/s12931-020-01526-6","title":"NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma","year":2020,"lang":"en","type":"article","venue":"Respiratory Research","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca; Amgen","keywords":"Medicine; Asthma; Clinical endpoint; Placebo; Exacerbation; Randomized controlled trial; Population; Thymic stromal lymphopoietin; Quality of life (healthcare); Internal medicine; Pediatrics; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002444499,0.001645313,0.002790761,0.0003923641,0.0006287007,0.001146931,0.001100195,0.002254479,0.00790568],"category_scores_gemma":[0.002213895,0.0006263285,0.001991726,0.0003306044,0.001255916,0.001384112,0.0006065528,0.003127419,0.001006129],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006305147,"about_ca_system_score_gemma":0.001614923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007215136,"about_ca_topic_score_gemma":0.001970603,"domain_scores_codex":[0.9990894,0.0004523299,0.00005402944,0.0001976166,0.00008008652,0.0001265427],"domain_scores_gemma":[0.9989622,0.0002434199,0.0002922416,0.00007982182,0.00007867299,0.0003436404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9762429,0.005789201,0.0006545663,0.0008447396,0.00079359,0.00004007577,0.00007387326,0.000198095,0.002504698,0.0001644077,0.001358771,0.01133514],"study_design_scores_gemma":[0.9701679,0.02829639,0.0006766468,0.00002397759,0.0001582423,0.00002147057,0.00001105694,0.000122466,0.0001039697,0.00007704659,0.0003344052,0.000006403357],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9665794,0.007335091,0.001703314,0.00139095,0.001021795,0.0150902,0.002994391,0.0004805225,0.003404373],"genre_scores_gemma":[0.9565268,0.003338009,0.005503478,0.002967987,0.0007665462,0.02497928,0.002363083,0.000076741,0.003477939],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00790568,"threshold_uncertainty_score":0.02644718,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05276660866435836,"score_gpt":0.3750711105603604,"score_spread":0.3223045018960021,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}